South Korea’s CoresteamChemo Partners with ATG Lifetech to Expand Global CRO Footprint
Seoul, South Korea Two of South Korea’s leading biotech innovators, CoresteamChemo and ATG Lifetech, have announced a strategic partnership aimed […]
NKGen Biotech and HekaBio Forge Powerful Alliance to Launch Next-Gen NK Cell Therapy in Japan
Tokyo, Japan A transformative leap in Japan’s regenerative medicine landscape is underway as NKGen Biotech, a US-based clinical-stage biotech innovator,
North America Leading the Global Healthcare Innovation Wave in 2024
In 2024, North America took center stage in the global healthcare and life sciences market, setting the pace for innovation,
Asia Pacific on the Rise: The Fastest-Growing Pharma Market? You Bet!
The Asia Pacific drug market is heating up and fast. With an aging population, rising cases of chronic diseases, and
The U.S. Bispecific Antibody Market Trends: What’s Fueling the Growth?
Across the globe, the bispecific antibody market is gaining momentum but no region is making a bigger impact than the
Why Did North America Lead the Anti-Seizure Medication Market in 2024?
In 2024, North America emerged as the undisputed leader in the anti-seizure medication market thanks to a combination of strong
Tulane University and 60 Degrees Pharmaceuticals Partner to Study New Lyme Disease Treatment
60 Degrees Pharmaceuticals, a company focused on developing medicines for infectious diseases, has entered a research partnership with Tulane University
10x Genomics and A*STAR Singapore Team Up to Revolutionize Cancer and Inflammatory Disease Research
10x Genomics, a leader in spatial biology and single-cell analysis, has joined forces with the Genome Institute of Singapore (A*STAR
Lisata and WARPNINE Complete First Stage of Promising Pancreatic Cancer Trial in Australia
Lisata Therapeutics and WARPNINE, a non-profit clinical research group in Western Australia, have announced the successful completion of patient enrollment
New Study Finds Key Marker That May Improve Pancreatic Cancer Treatment for Younger Patients
Sapu Biosciences, a subsidiary of GMP Biotechnology Limited, has partnered with Oncotelic Therapeutics to publish groundbreaking research that could change